The transition from injection to non-injection drug use: long-term outcomes among heroin and cocaine users in New York City.
- Authors
- Des Jarlais, Don C; Arasteh, Kamyar; Perlis, Theresa; Hagan, Holly; Heckathorn, Douglas D; Mcknight, Courtney; Bramson, Heidi; Friedman, Samuel R
- Year
- 2007
- Journal
- Addiction (Abingdon, England)
- PMID
- 17506155
- DOI
- 10.1111/j.1360-0443.2007.01764.x
AIMS: To characterize heroin and cocaine users in New York City who have changed from injection to non-injection drug administration and to identify factors associated with long-term non-injection use. DESIGN: Two cross-sectional studies of heroin and cocaine users in New York City. SETTINGS AND PARTICIPANTS: New admissions were recruited at drug abuse treatment programs (2000-04) and respondent-driven sampling was used to recruit drug users from the community (2004). Both injecting and non-injecting drug users participated in each study. 'Former injectors' were defined operationally as people who had used heroin and/or cocaine in the 6 months prior to the interview and who had injected illicit drugs in the past, but whose most recent injection was more than 6 months before the study interview. 'Current' injectors were defined as people who had injected heroin and/or cocaine in the 6 months prior to the interview. MEASUREMENTS: A structured interview on drug use history was administered, and a serum sample was collected and tested for the human immunodeficiency virus (HIV). FINDINGS: A total of 104 former injectors was recruited for the drug abuse treatment program study, and 229 current injectors were recruited for the community recruitment study; 160 former injectors and 1731 current injectors were recruited from the drug abuse treatment study. Compared with the current injectors, former injectors were older and more likely to be African American. The former injectors reported long intervals since their most recent injection, a mean of 8 years in the drug abuse treatment program study and a mean of 12 years in the community recruitment study. The most common reasons for stopping injection drug use included concerns about health, social stigmatization and self-image, and preference for intranasal use as a route of drug administration. The results were highly consistent across the two studies. CONCLUSIONS: The transition from injection to non-injection use appears to be relatively stable behavior change for many former injectors, who report a decade or more without injecting. Developing a greater understanding of the transition from injection to stable non-injection drug use may provide insights into the natural histories of drug use and addiction.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
In this knowledge base
| Title | Year | PMID |
|---|---|---|
| Evidence of CNIH3 involvement in opioid dependence. | 2016 | 26239289 |
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| A qualitative study exploring motives for the transition from injecting to smoking drugs in Vancouver, British Columbia. | Bonn M et al. | — | 2025 | → |
| Stability or versatility: transitions in fentanyl routes of administration. | Ondocsin J et al. | — | 2025 | → |
| Injecting drug use opportunities and reasons for choosing not to inject: A population-based study of Australian young adults who use stimulants. | Casey LE et al. | — | 2022 | → |
| Social network predictors of recent and sustained injection drug use cessation: findings from a longitudinal cohort study. | Rudolph AE et al. | — | 2021 | → |
| Community viral load and hepatitis C virus infection: Community viral load measures to aid public health treatment efforts and program evaluation. | Jordan AE et al. | — | 2020 | → |
| Cost-Effectiveness of Postoperative Drug Rehabilitation for Injection Drug Users. | Tyerman Z et al. | — | 2020 | → |
| Distance matters: The association of proximity to syringe services programs with sharing of syringes and injecting equipment - 17 U.S. cities, 2015. | Whiteman A et al. | — | 2020 | → |
| The switch from one substance-of-abuse to another: illicit drug substitution behaviors in a sample of high-risk drug users. | Shapira B et al. | — | 2020 | → |
| Harm reduction measures employed by people using opioids with suspected fentanyl exposure in Boston, Baltimore, and Providence. | Rouhani S et al. | — | 2019 | → |
| Prescription opioid misuse and comorbid substance use: Past 30-day prevalence, correlates and co-occurring behavioral indicators in the 2016 National Survey on Drug Use and Health. | Grigsby TJ et al. | — | 2019 | → |
| Toots, tastes and tester shots: user accounts of drug sampling methods for gauging heroin potency. | Mars SG et al. | — | 2018 | → |
| Cessation of Injecting and Preceding Drug Use Patterns Among a Prospective Cohort of Street-Involved Youth. | Hadland SE et al. | — | 2017 | → |
| Social-structural factors influencing periods of injection cessation among marginalized youth who inject drugs in Vancouver, Canada: an ethno-epidemiological study. | Boyd J et al. | — | 2017 | → |
| An exploration of alcohol use severity and route of drug administration among persons that use heroin and cocaine. | Scherer M et al. | — | 2016 | → |
| Evidence of CNIH3 involvement in opioid dependence. | Nelson EC et al. | — | 2016 | → |
| From initiating injecting drug use to regular injecting: Retrospective survival analysis of injecting progression within a sample of people who inject drugs regularly. | O'Keefe D et al. | — | 2016 | → |
| From Long-Term Injecting to Long-Term Non-Injecting Heroin and Cocaine Use: The Persistence of Changed Drug Habits. | Jarlais DC et al. | — | 2016 | → |
| Using Respondent-Driven Sampling to Recruit Illegal Drug Purchasers to Evaluate a Drug Market Intervention. | Ober AJ et al. | — | 2016 | → |
| Evaluation of Femoral Ultrasonography as a Tool for Promoting Cessation of Groin-Injecting Behaviour. | Senbanjo R et al. | — | 2015 | → |
| Formal and informal organizational activities of people who inject drugs in New York City: description and correlates. | Friedman SR et al. | — | 2015 | → |
| Increasing prevalence of HIV infection among first time clients in Italian drug treatment services - is it sexual transmission? | Cruciani M et al. | — | 2015 | → |
| Differences in sociodemographic, drug use and health characteristics between never, former and current injecting, problematic hard-drug users in the Netherlands. | Havinga P et al. | — | 2014 | → |
| Transitions from injecting to non-injecting drug use: potential protection against HCV infection. | Des Jarlais DC et al. | — | 2014 | → |
| Understanding the rural-urban differences in nonmedical prescription opioid use and abuse in the United States. | Keyes KM et al. | — | 2014 | → |
| Decreased injecting is associated with increased alcohol consumption among injecting drug users in northern Vietnam. | Go VF et al. | — | 2013 | → |
| High HIV prevalence among low-income, Black women in New York City with self-reported HIV negative and unknown status. | Reilly KH et al. | — | 2013 | → |
| Are females who inject drugs at higher risk for HIV infection than males who inject drugs: an international systematic review of high seroprevalence areas. | Des Jarlais DC et al. | — | 2012 | → |
| Injecting transition risk and depression among Mexican American non-injecting heroin users. | Cepeda A et al. | — | 2012 | → |
| Multiple routes of drug administration and HIV risk among injecting drug users. | Vorobjov S et al. | — | 2012 | → |
| Premature mortality in Scottish injecting drug users: a life-history approach. | Copeland L et al. | — | 2012 | → |
| Racial and ethnic disparities and implications for the prevention of HIV among persons who inject drugs. | Jarlais DC et al. | — | 2012 | → |
| Transition to injection amongst opioid users in Iran: implications for harm reduction. | Malekinejad M et al. | — | 2012 | → |
| Associations between herpes simplex virus type 2 and HCV With HIV among injecting drug users in New York City: the current importance of sexual transmission of HIV. | Des Jarlais DC et al. | — | 2011 | → |
| Can intranasal drug use reduce HCV infection among injecting drug users? | Des Jarlais DC et al. | — | 2011 | → |
| Comparison of HIV risk by duration of injection drug use. | Vlahov D et al. | — | 2011 | → |
| HIV among drug users at Beth Israel Medical Center, New York City, the first 25 years. | Des Jarlais DC et al. | — | 2011 | → |
| Individual and network factors associated with non-fatal overdose among rural Appalachian drug users. | Havens JR et al. | — | 2011 | → |
| Individual, social, and environmental factors associated with initiating methamphetamine injection: implications for drug use and HIV prevention strategies. | Marshall BD et al. | — | 2011 | → |
| Trajectories of injection drug use over 20 years (1988-2008) in Baltimore, Maryland. | Genberg BL et al. | — | 2011 | → |
| Typologies of prescription opioid use in a large sample of adults assessed for substance abuse treatment. | Green TC et al. | — | 2011 | → |
| Understanding subtypes of inner-city drug users with a latent class approach. | Kuramoto SJ et al. | — | 2011 | → |
| Commentary on Salmon et al. (2010): The case for safer inhalation facilities--waiting to inhale. | Strathdee SA et al. | — | 2010 | → |
| High risk behavior for HIV transmission among former injecting drug users: a survey from Indonesia. | Iskandar S et al. | — | 2010 | → |
| HIV infection during limited versus combined HIV prevention programs for IDUs in New York City: the importance of transmission behaviors. | Des Jarlais DC et al. | — | 2010 | → |
| Prevalence and correlates of former injection drug use among young noninjecting heroin users in Chicago. | Broz D et al. | — | 2010 | → |
| Route transition interventions: potential public health gains from reducing or preventing injecting. | Bridge J | — | 2010 | → |
| Syringe exchange, injecting and intranasal drug use. | Des Jarlais DC et al. | — | 2010 | → |
| Transition to and from injecting drug use among regular ecstasy users. | Dunn M et al. | — | 2010 | → |
| Balancing the costs and benefits of opioid analgesics in the United States. | Coffin PO | — | 2009 | → |
| Crack cocaine use and its relationship with violence and HIV. | Carvalho HB et al. | — | 2009 | → |
| Comparing heroin users and prescription opioid users in a Canadian multi-site population of illicit opioid users. | Fischer B et al. | — | 2008 | → |